Forward Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
EIP
Forward Management's CLB Position: Q4 2018 in Review
Forward Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 2,571 shares — an estimated $298K sold.
Forward Management first reported a position in CLB in Q1 2015 and held it in 15 quarters. The position peaked at $994K in Q2 2015. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.
- Forward Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
- Forward Management sold 2,571 Core Laboratories shares in Q4 2018, an estimated $298K.
- Forward Management first reported a position in Core Laboratories in Q1 2015 and held it in 15 quarters.
- Forward Management's Core Laboratories position peaked at $994K in Q2 2015.
- 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.
Based on Forward Management's 13F filing for Q4 2018, filed 1 Feb 2019.